Monday, May 25, 2009

Blog Release: Discovering Drugs to Prevent or Reverse Alzheimer's Disease

From Audrey Russo, President of the Pittsburgh Technology Council:

Please note that this event is open to anyone who is interested in attending, male or female. The PghTech Women’s NetworkTM has agreed to partner with Cognition Therapeutics, Inc. and open this event to the public because of the important content of the presentation and the widespread affects of Alzheimer’s disease. However, pre-registration is required! Please use the registration information below and RSVP by May 27.

Thursday May 28, 2009, Dr. Susan Catalano, Founder and Chief Science Officer, Cognition Therapeutics Inc. presents "Discovering drugs to prevent or reverse Alzheimer's disease"

Alzheimer's disease affects more than 5.3 million Americans, and will soar to more than 11 million by 2040: one out of eight baby-boomers will get Alzheimer's. Today, the direct costs to Medicare and Medicaid for care of people with Alzheimer's and other dementias and the indirect costs to business for employees who are caring for Alzheimer's are estimated at more than $148 billion annually. Seventy percent of Alzheimer's patients live at home, and nearly 10 million Americans provide 8.5 billion hours of unpaid care valued at $94 billion to people with Alzheimer's disease or other dementias. This month's HBO documentary "The Alzheimer's Project" highlights the basic research being done to uncover the basic features of the disease (

Dr. Catalano will describe the cutting edge science being done by Cognition Therapeutics right here in Pittsburgh to discover drugs to halt or reverse the underlying pathological changes in the brain that cause Alzheimer's disease, and lead a tour of the company's laboratories on the South Side.


5:30 - 6 p.m.

Wine and hors d'ouvres reception

6 - 6:45 p.m.

Lecture and discussion with Dr. Susan Catalano

6:45 - 7 p.m.

Tour of the Lab

Speaker Profile:
Dr. Catalano has extensive experience in the field of Alzheimer’s disease drug discovery. She served as Director of Discovery Biology for South San Francisco-based startup Acumen Pharmaceuticals, Inc., where she led a scientific team to the development of novel, first-in-class assay systems responsible for the discovery of the company’s first small molecule lead candidates targeting oligomers. Dr. Catalano has over 14 years of experience as a cell biologist in the fields of neuroscience and oncology, and nine years of experience in the drug discovery industry. Dr. Catalano received her Ph.D. from U.C. Irvine and postdoctoral training at U.C. Berkeley and Caltech in the field of neurobiology. While a scientist at Roche Palo Alto, she held leadership positions in the Neurophysiology and Neuroimaging groups and led exploratory programs against targets involved in anxiety, depression and schizophrenia. Following this, Dr. Catalano joined Rigel Pharmaceuticals, Inc. as a Senior Scientist and pioneered the use of high content phenotypic screening technology to discover R763, an Aurora kinase inhibitor that recently began its third PhI clinical trial. Dr. Catalano founded Cogntion Therapeutics in 2007, and re-located the company to Pittsburgh from California to take advantage of the world-class neuroscience research, highly educated workforce and synergies with local companies that the city offers.

PghTech Women
NetworkTM is sponsored by Google.


Thursday, May 28


5:30 - 7 p.m.


Cognition Therapeutics Inc., 2403 Sidney Street, Second Floor, 15203


$10 Council Members - $30 Non-Members


E-mail | 412.918.4229

For our event on April 30th, free parking is available after 5 p.m. anywhere in the front lot of River Park Commons, available spaces on both sides of the building, in the lot behind the building and in the lot on the left at the end of 24th Street.

The front lot parking can be accessed two ways:

  • From 25th Street make a left onto Sidney and enter the lot from Sidney
  • From 24th Street, cross over Sidney, continue a short distance and make the first right into the front lot

On-street parking as well as limited metered parking is also available in the area. Please know the City does monitor and ticket expired meters.

After you have parked, walk to the front of River Park Commons and come in through the main entrance. You will be directed to the second floor to Suite 200, across the hall from the laboratories of Cognition Therapeutics Inc.

No comments: